Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An evaluation on potential anti-inflammatory effects of β-lapachone.
Mokarizadeh N, Karimi P, Kazemzadeh H, Fathi Maroufi N, Sadigh-Eteghad S, Nikanfar S, Rashtchizadeh N. Mokarizadeh N, et al. Among authors: kazemzadeh h. Int Immunopharmacol. 2020 Oct;87:106810. doi: 10.1016/j.intimp.2020.106810. Epub 2020 Jul 21. Int Immunopharmacol. 2020. PMID: 32707497 Review.
The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor.
Maroufi NF, Ashouri N, Mortezania Z, Ashoori Z, Vahedian V, Amirzadeh-Iranaq MT, Fattahi A, Kazemzadeh H, Bizzarri M, Akbarzadeh M, Nejabati HR, Faridvand Y, Rashidi MR, Nouri M. Maroufi NF, et al. Among authors: kazemzadeh h. Pathol Res Pract. 2020 Oct;216(10):153226. doi: 10.1016/j.prp.2020.153226. Epub 2020 Sep 19. Pathol Res Pract. 2020. PMID: 32987338 Review.
Vascular mimicry: A potential therapeutic target in breast cancer.
Chavoshi H, Poormolaie N, Vahedian V, Kazemzadeh H, Mir A, Nejabati HR, Behroozi J, Isazadeh A, Hajezimian S, Nouri M, Maroufi NF. Chavoshi H, et al. Among authors: kazemzadeh h. Pathol Res Pract. 2022 Jun;234:153922. doi: 10.1016/j.prp.2022.153922. Epub 2022 Apr 27. Pathol Res Pract. 2022. PMID: 35500501 Review.
The role of SOX family in cancer stem cell maintenance: With a focus on SOX2.
Pouremamali F, Vahedian V, Hassani N, Mirzaei S, Pouremamali A, Kazemzadeh H, Faridvand Y, Jafari-Gharabaghlou D, Nouri M, Maroufi NF. Pouremamali F, et al. Among authors: kazemzadeh h. Pathol Res Pract. 2022 Mar;231:153783. doi: 10.1016/j.prp.2022.153783. Epub 2022 Jan 29. Pathol Res Pract. 2022. PMID: 35121364 Review.
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.
Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, Najafizadeh SR, Farhadi E, Jalili N, Esfahani M, Rahimi B, Kazemzadeh H, Mahmoodi Aliabadi M, Ghazanfari T, Sattarian M, Ebrahimi Louyeh H, Raeeskarami SR, Jamalimoghadamsiahkali S, Khajavirad N, Mahmoudi M, Rostamian A. Edalatifard M, et al. Among authors: kazemzadeh h. Eur Respir J. 2020 Dec 24;56(6):2002808. doi: 10.1183/13993003.02808-2020. Print 2020 Dec. Eur Respir J. 2020. PMID: 32943404 Free PMC article. Clinical Trial.
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.
Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L, Kazemzadeh H, Yekaninejad MS. Davoudi-Monfared E, et al. Among authors: kazemzadeh h. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e01061-20. doi: 10.1128/AAC.01061-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32661006 Free PMC article. Clinical Trial.
13 results